Effect of Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated TumorKevin Kalinsky, Keith T. Flaherty, Fangxin Hong et al.|JAMA Oncology|2020Cited by 106
A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal CarcinomatosisKim A. Reiss, Nilofer S. Azad, Marianna Zahurak et al.|Clinical Cancer Research|2014Cited by 75
A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancersKim A. Reiss, Nilofer S. Azad, Joseph M. Herman et al.|Gynecologic Oncology|2017Cited by 53
Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discoveryJessica Karielle Tan, Charles Y. Chiu, Venice Servellita et al.|Nature Communications|2024Cited by 48
Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumorsShivaani Kummar, Alice P. Chen|Investigational New Drugs|2021Cited by 7